248 related articles for article (PubMed ID: 3134381)
1. Currently available lipid-lowering agents.
Levy RI
Hosp Pract (Off Ed); 1988 Jun; 23 Suppl 1():14-21. PubMed ID: 3134381
[No Abstract] [Full Text] [Related]
2. Making the most of cholesterol-lowering margarines.
Avery JK
Cleve Clin J Med; 2001 Mar; 68(3):194-6. PubMed ID: 11263847
[TBL] [Abstract][Full Text] [Related]
3. Practical drug therapy for common hyperlipidaemias.
Tikkanen MJ
Baillieres Clin Endocrinol Metab; 1990 Dec; 4(4):719-42. PubMed ID: 2082904
[No Abstract] [Full Text] [Related]
4. Selection of appropriate type and intensity of lipid-lowering therapy.
Tikkanen MJ
Curr Opin Lipidol; 1995 Dec; 6(6):360-4. PubMed ID: 8750248
[TBL] [Abstract][Full Text] [Related]
5. The ineffectiveness of a commonly recommended lipid-lowering diet in significantly lowering the serum total and low-density lipoprotein cholesterol levels.
Roberts WC
Am J Cardiol; 1994 Mar; 73(8):623-4. PubMed ID: 8147319
[No Abstract] [Full Text] [Related]
6. [Lipid lowering therapy for primary prevention of coronary heart disease--contra lipid lowering therapy].
Berger M
Z Kardiol; 1998; 87 Suppl 2():210-3. PubMed ID: 9827485
[TBL] [Abstract][Full Text] [Related]
7. Therapy and clinical trials.
Cramb R
Curr Opin Lipidol; 1998 Aug; 9(4):381-3. PubMed ID: 9739497
[No Abstract] [Full Text] [Related]
8. Dietary and pharmacologic therapy for the lipid risk factors.
JAMA; 1983 Oct; 250(14):1873-9. PubMed ID: 6620484
[No Abstract] [Full Text] [Related]
9. [Effectiveness of new lipotropic preparations in hyperlipemia].
Miasnikov LA; Bavina MV; Lobova NM; Koropova GI
Kardiologiia; 1971 Aug; 11(8):26-30. PubMed ID: 5160871
[No Abstract] [Full Text] [Related]
10. [Efficacy and safety of simvastatin in patients with hypercholesterolemia (results of a Multicenter Clinical Study)].
Kukharchuk VV; Bubnova MG; Katel'nitskaia LI; Nikitin IuP; Ol'binskaia LI;
Kardiologiia; 2003; 43(5):42-7. PubMed ID: 12891239
[TBL] [Abstract][Full Text] [Related]
11. Lipid disorders in NIDDM: implications for treatment.
Taskinen MR; Smith U
J Intern Med; 1998 Nov; 244(5):361-70. PubMed ID: 9845851
[TBL] [Abstract][Full Text] [Related]
12. Primary prevention of ischaemic heart disease with lipid-lowering drugs.
Lancet; 1988 Feb; 1(8581):333-4. PubMed ID: 2893141
[No Abstract] [Full Text] [Related]
13. Updating a 12-year experience with arrest and reversal therapy for coronary heart disease (an overdue requiem for palliative cardiology).
Esselstyn CB
Am J Cardiol; 1999 Aug; 84(3):339-41, A8. PubMed ID: 10496449
[TBL] [Abstract][Full Text] [Related]
14. The case for aggressive lipid regulation.
Gotto AM
Hosp Pract (1995); 1997 Feb; 32(2):145-9, 155-6. PubMed ID: 9040426
[TBL] [Abstract][Full Text] [Related]
15. [KLAS [Kanazawa Lipid Assessment Survey]].
Mabuchi H; Inazu A; Higashikata T; Nohara A; Koizumi J
Nihon Rinsho; 2001 Mar; 59 Suppl 3():469-76. PubMed ID: 11347115
[No Abstract] [Full Text] [Related]
16. Focus on fenofibrate.
Brown WV
Hosp Pract (Off Ed); 1988 Jun; 23 Suppl 1():31-40. PubMed ID: 3134383
[No Abstract] [Full Text] [Related]
17. A case for lipid-lowering?
Durrington P
Diabet Med; 2000 Sep; 17 Suppl 2():4-5. PubMed ID: 11048824
[No Abstract] [Full Text] [Related]
18. [Therapeutic management of the dyslipidemic patient].
Agence Française de Sécurité Sanitaire des Produits de Santé
Ann Endocrinol (Paris); 2001 Feb; 62(1 Pt 1):70-5. PubMed ID: 11240406
[No Abstract] [Full Text] [Related]
19. [Treatment of high blood cholesterol in patients with coronary heart disease].
Nagai Y; Yamashita S
Nihon Rinsho; 2003 Apr; 61 Suppl 4():675-81. PubMed ID: 12735049
[No Abstract] [Full Text] [Related]
20. [Prevention of coronary heart disease by therapy of hyperlipidemia. Between cholesterol hysteria and therapeutic realism].
Deller M; Huth K
Fortschr Med; 1992 Sep; 110(25):463-6. PubMed ID: 1398397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
